Aion Therapeutics’ (AION.C) joint testing with Apollon Formularies has revealed that their combined formulations are effective in killer HER-positive (HER2+) breast cancer cells. “Our recent medicinal mushroom formulation testing…
AION.C
Aion Therapeutics’ (AION.C) proprietary and patented combinatorial mushroom preparations, Aion F7 and Aion F8, have shown high efficacy in killing HER2+ breast cancer cells, ER+/PR+ breast cancer cells, and…
Aion Therapeutics (AION.C), formerly Osoyoos Cannabis, has filed four new patent applications related to preparations of medicinal and psychedlics mushrooms. This brings the Company’s total patent applications up to 9…